The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...

Timothy Patrick Flynn, a director at UnitedHealth Group Inc. (NYSE:UNH), recently purchased 1,000 shares of the company's common stock. The transaction, dated January 17, 2025, was made at a price of ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...